Viking Therapeutics shares fall approximately 23% below capital increase issue price
VKTX Viking Therapeutics Inc
$28.44 -0.77%
View chart & analysis → - 1Analysts predict the obesity treatment market will reach approximately $100 billion by the end of the 2010s.
- 2Viking raised $575 million through a capital increase last month.
- 3The current stock price shows a 23% decline compared to Viking's $35 capital increase issue price.
So what's the key point?
Viking Therapeutics raised money by issuing new shares, but the current stock price has fallen 23% below that price. This may be a point of concern for investors as the obesity treatment market is expected to grow.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.